Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0331754 THERAPIES FOR TREATING CANCERS
Provided herein are methods, compositions, and kits for treating myeloproliferative disorders or neoplasms, including polycythemia vera, primary myelofibrosis,...
2016/0331753 HETEROCYCLYL COMPOUNDS AS MEK INHIBITORS
The present disclosure is related to heteroaryl compounds as MEK inhibitors. These compounds include heteroaryl compounds of formula I, their pharmaceutically...
2016/0331752 RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION
A risperidone sustained release microsphere formulation is provided. The microsphere formulation includes risperidone or 9-hydroxy risperidone or salts...
2016/0331751 PHARMACEUTICAL COMPOSITIONS
The disclosure relates to a pharmaceutical combination of a mdm2/4 inhibitor, namely ...
2016/0331750 METHODS FOR TREATMENT OF LYMPHOMAS WITH MUTATIONS IN CELL CYCLE GENES
The present disclosure identifies a novel subtype of follicular lymphoma (FL) characterized by dysregulation of the cyclin/CDK/RB proliferative pathway. This...
2016/0331749 BROMODOMAIN INHIBITORS
The present invention provides for compounds of formula (I) ##STR00001## wherein Y.sup.1, Y.sup.2, R.sup.1, R.sup.2, R.sup.3, A.sup.1, A.sup.2, A.sup.3, and...
2016/0331748 A 6-oxo-1,6-dihydro-pyridazine derivative for the use for the treatment of renal cell carcinoma (RCC)
3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo- -1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt...
2016/0331747 PHARMACEUTICAL FORMULATION FOR REDUCING FREQUENCY OF URINATION AND METHOD OF USE THEREOF
Methods and compositions for reducing frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount...
2016/0331746 Sortilin-Binding Small Molecules for Increasing Glucose Uptake
Various scaffolds of small molecules capable of binding to the active site of sortilin are identified by in silico methods. These scaffolds include norbornene...
2016/0331745 Topical Brimonidine Tartrate Ophthalmic Solution
The present invention provides an aqueous ophthalmic composition comprising an alpha-2 adrenergic receptor agonist and a non-ionic cellulosic polymer, the...
2016/0331744 pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
An aerosolizable formulation comprised of a drug, a carrier and pH affecting component is disclosed. The drug is dissolved in the formulation at a...
2016/0331743 PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER
The present invention relates to the field of cancer treatment, in particular to the treatment of carcinoma in situ bladder cancer and the provision of...
2016/0331742 TREATMENT OF CROHN'S DISEASE USING LOW DOSES OF LAQUINIMOD
This invention provides a method of treating a subject suffering from Crohn's disease, comprising periodically administering to the subject an amount of...
2016/0331741 CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR
The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of...
2016/0331740 TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF
A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a...
2016/0331739 METHODS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH HYPERLIPIDEMIA AND HYPERCHOLESTEROLEMIA WHILE...
The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an...
2016/0331738 DRUG DELIVERY FROM HYDROGELS
Drug delivery involving hydrogels as used for various medical conditions, and includes hydrogels formed in an eye with extended drug release times. An...
2016/0331737 METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE
The invention provides enantiopure deuterium-enriched pioglitazone, pharmaceutical compositions, and methods of treating neurological disorders, cancer,...
2016/0331736 DRUG FOR TREATING CORNEAL ENDOTHELIUM BY PROMOTING CELL PROLIFERATION OR INHIBITING CELL DAMAGE
Provided is an agent for treating or preventing a corneal endothelial disorder wherein cell proliferation is required. More specifically, provided is an agent...
2016/0331735 NOVEL FORMULATIONS FOR TREATMENT OF PAIN, NEUROPATHY, WOUNDS, AND ULCERS
The present disclosure describes various pharmaceutical formulations and compounds for transdermal treatment of pain, neuropathy, wounds and ulcers. The...
2016/0331734 SUBSTITUTED N-ARYL PYRIDINONES
Disclosed herein are substituted N-Aryl pyridinone fibrotic inhibitors and/or collagen infiltration modulators of Formula (I), process of preparation thereof,...
2016/0331733 NEW USE OF ACLIDINIUM
The present disclosure provides aclidinium or any of its stereoisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof,...
2016/0331732 NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
Aerosol formulations of granisetron useful for pulmonary delivery are provided. The formulations are useful in the reduction, elimination or prevention of...
2016/0331731 USE OF PSORALEN DERIVATIVES AND COMBINATION THERAPY FOR TREATMENT OF CELL PROLIFERATION DISORDERS
Methods for the treatment of a cell proliferation disease or disorder in a subject, involving applying a psoralen derivative lacking a DNA cross-linking motif...
2016/0331730 Antifungal Compounds
The technical field of the invention is in pharmaceutical compounds and methods. In an aspect, the disclosure provides macrolide compounds suitable for use as...
2016/0331729 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS
The present invention relates to methods of treating or preventing addiction and relapse use of addictive agents, and treating or preventing addictive or...
2016/0331728 MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE
The present invention provides compositions and methods useful for diagnosing, treating, and monitoring alcohol dependence and disorders and susceptibility to...
2016/0331727 METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective...
2016/0331726 TREATMENT AND DIAGNOSIS OF MELANOMA
The present invention discloses novel agents and methods for diagnosis and treatment of melanoma. Also disclosed are related arrays, kits, and screening methods.
2016/0331725 USE OF COMPOUNDS THAT ARE ABLE TO INCREASE THE SERUM IGF-1 LEVEL FOR THE PREPARATION OF A THERAPEUTICAL...
The present disclosure relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for...
2016/0331724 PHARMACEUTICAL COMPOSITION COMPRISING A BIGUANIDE DERIVATIVE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING...
The present invention provides novel uses of a biguanide derivative for preventing or treating glioblastoma. The compound of Formula 1 and its pharmaceutically...
2016/0331723 PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT AND/OR HYPERACTIVITY
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of attention...
2016/0331722 Electrophilically Enhanced Phenolic Compounds for Treating Inflammatory Related Diseases and Disorders
A therapeutic compound has a modified phenolic compound of the general formula (I) ##STR00001## wherein at least one of R, R.sub.1, R.sub.2, R.sub.3, and...
2016/0331721 COMPOSITION FOR ALLEVIATING AND PREVENTING ALZHEIMER'S DISEASE
The present invention provides a composition for alleviating and preventing Alzheimer's disease. This composition comprises at least one yellow pigment...
2016/0331720 SCALEABLE CANNABINOID TREATMENT REGIMINE AND MEDICINAL FORMULATIONS
The present invention administers a cannabinoid medication to a patient followed by observing one or more physiological responses in the patient during a first...
2016/0331719 NATURAL PRODUCT ANTIBIOTICS AND ANALOGS THEREOF
Provided herein are pure and isolated natural products and analogs thereof of Formula (I), (II), (III), and (IV), pharmaceutical compositions thereof, and...
2016/0331718 9, 10-ALPHA, ALPHA-OH-TAXANE ANALOGS AND METHOD FOR PRODUCTION THEREOF
Provided herein are compounds, compositions containing the compounds, and methods for the treatment of cancer in a cancer patient. In particular, the compounds...
2016/0331717 CABAZITAXEL AND ITS USE FOR TREATING CANCER
The present invention relates to the compound having the following formula (I): ##STR00001## which may be in base form or in the form of a hydrate or a...
2016/0331716 MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
Molecular target for healing or treating wounds and, in particular chronic, human wounds, are described. The molecular target is PTPRK, or a protein 50%...
2016/0331715 BRIMONIDINE GEL COMPOSITIONS AND METHODS OF USE
Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain...
2016/0331714 THE USE OF A BENZOATE CONTAINING COMPOSITION IN UREA CYCLE DISORDERS AND NEURODEGENERATIVE DISORDERS
This disclosure relates to pharmaceutical compositions useful for inhibiting the progression of urea cycle disorders and neurodegenerative disorders, such as...
2016/0331713 METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION
A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic...
2016/0331712 COMPOSITIONS OF OMEGA 3 FATTY ACIDS TO TREAT DISEASES WHICH INVOLVE DAMAGE TO THE NERVOUS SYSTEM
Compositions comprising omega 3 fatty acids for use in the treatment, amelioration or prevention of various conditions, disorders, and diseases which involve...
2016/0331711 ALDITOL-FREE, STORAGE-STABLE THYROID HORMONE ACTIVE DRUG FORMULATIONS AND METHODS FOR THEIR PRODUCTION
Embodiments of the present invention provide pharmaceutical compositions in unit dosage form that comprise a therapeutically effective amount of levothyroxine...
2016/0331710 EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE
Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent...
2016/0331709 Balancing an Unbalanced Sympathetic Nervous System
Many illnesses generally result from chemical imbalances and deficiencies in the Sympathetic Nervous System. The composition of the invention provides the body...
2016/0331708 MEANS AND METHODS FOR INCREASING ANTIBIOTIC ACTIVITY
The disclosure provides means and methods for increasing the activity of antibiotics. This enables the use of lower antibiotic dosages and the treatment of...
2016/0331707 ANTIOXIDANT COMPOSITIONS FOR TREATMENT OF INFLAMMATION OR OXIDATIVE DAMAGE
One embodiment of the invention is directed to a method of preventing, reducing, or eliminating at least one negative effect of oxidative damage, such as an...
2016/0331706 Compositions and Methods for Treating Cardiovascular Diseases
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a...
2016/0331705 ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.